Chun-Wei Wang

Chun-Wei Wang


Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 October 2013 in Strahlentherapie und Onkologie
Verified
Journal Article
Closed access
PDF file
JCJ.L.-Y. Chen
J.L.-Y. Chen
YHY.-S. Huang
Y.-S. Huang
SKSung-Hsin Kuo
Sung-Hsin Kuo
YCY.-F. Chen
Y.-F. Chen
RHR.-L. Hong
R.-L. Hong
CWChun-Wei Wang
Chun-Wei Wang

22 October 2013 in Radiation Oncology
Verified
Journal Article
Open access
PDF file
WCWan-Yu Chen
Wan-Yu Chen
CWChun-Wei Wang
Chun-Wei Wang
CCChin-Hao Chang
Chin-Hao Chang
HLHeng-Hsiu Liu
Heng-Hsiu Liu
KLKeng-Hsueh Lan
Keng-Hsueh Lan
LCLi-Tzong Chen
Li-Tzong Chen
Background: To evaluate clinicopathological features, radiotherapeutic parameters, and their associations with responses to radiotherapy (RT) in patients with myeloid sarcoma (MS).Methods: We reviewed 20 patients receiving RT for MS lesions (in 43 RT courses) and analyzed the patients’ clinicopathologic features and radiotherapeutic parameters, and their associations with complete responses (CR) to RT using Fisher’s exact test and univariate logistic regression analysis. Generalized Estimating Equation was used to analyze all 43 irradiated lesions and account for the correlations in RT responses among lesions from the same patient.Results: We found that the underlying hematological diseases of the evaluated patients were acute myeloid leukemia (AML) in 14 patients (70%), chronic myeloid leukemia in 4 patients (20%), myelodysplastic syndrome with AML transformation in one patient (5%), and de novo MS in one patient (5%). Most patients (55%) received RT for MS at the time of relapse following bone marrow transplantation (BMT). The most common cytogenetic abnormality was t(8;21)(q22;q22). The median RT dose of 20 Gy (range 6–35 Gy), administered in 1.5-3.5 Gy fractions, provided a 63% CR rate. RT dose, sex, cytogenetics, and bone marrow status at the time of RT had no significant effect on CR. Younger age (<50 y,P = 0.06), BMT prior to RT (P = 0.05), and underlying AML (P = 0.05) were marginally associated with higher CR to RT.Conclusions: Our results indicate that a modest RT dose (20-30 Gy) achieves good local control of MS. Age, previous BMT, and underlying hematologic disease can affect RT response.

28 August 2018 in Radiation Oncology
Verified
Journal Article
Open access
PDF file
WCWan-Yu Chen
Wan-Yu Chen
YCYih-Leong Chang
Yih-Leong Chang
CWChun-Wei Wang
Chun-Wei Wang
KLKeng-Hsueh Lan
Keng-Hsueh Lan
HLHsiang-Kuang Liang
Hsiang-Kuang Liang
LCLi-Tzong Chen
Li-Tzong Chen
Our aim was to investigate the prognostic significance of tumor-infiltrating lymphocytes (TILs) in operable tongue cancer patients. The presence of CD3+, CD4+, CD8+, and forkhead box protein P3-positive (FOXP3+) TILs in tumor tissues obtained from 93 patients during surgery was examined using immunohistochemistry. The 3-year overall survival (OS) of patients with a low CD8/FOXP3 ratio was significantly lower than that of patients with a high CD8/FOXP3 ratio (63.8% vs. 87.3%, p = 0.001). Patients with high FOXP3 had a significantly lower 3-year regional recurrence-free survival (RRFS) than did patients with low FOXP3 (49.3% vs. 87.3%, univariate log rank p = 0.000). A low CD4/FOXP3 ratio (68.4% vs. 93.7%, univariate log rank p = 0.002) was significantly unfavorable prognostic factors for 3-year distant metastasis-free survival (DMFS). In addition to clinicopathological characteristics, TIL markers represent prognosticators for clinical outcomes.

18 October 2016 in Oncotarget
Verified
Journal Article
Open access
PDF file
JCJenny Ling-Yu Chen
Jenny Ling-Yu Chen
YHYu-Sen Huang
Yu-Sen Huang
SKSung-Hsin Kuo
Sung-Hsin Kuo
RHRuey-Long Hong
Ruey-Long Hong
JKJenq-Yuh Ko
Jenq-Yuh Ko
CWChun-Wei Wang
Chun-Wei Wang
Intensity-modulated radiation therapy achieves better local control compared to three-dimensional conformal radiation therapy for T4-stage nasopharyngeal carcinoma

31 August 2022 in Oxidative Medicine and Cellular Longevity
Verified
Journal Article
Open access
PDF file
MWMing-Feng Wei
Ming-Feng Wei
CCChing-Hsueh Cheng
Ching-Hsueh Cheng
SWShu-Yu Wen
Shu-Yu Wen
JLJui-Chueh Lin
Jui-Chueh Lin
YCYu-Hsuan Chen
Yu-Hsuan Chen
SKSung-Hsin Kuo
Sung-Hsin Kuo
Abdominal or pelvic radiotherapy (RT) often results in small intestinal injury, such as apoptosis of epithelial cells and shortening of the villi. Atorvastatin, a 3‐hydroxy‐3‐methylglutaryl coenzyme A reductase inhibitor, has many biological effects including cholesterol reduction, protection from cell damage, and autophagy activation. To reduce the extent of radiotherapy‐ (RT‐) induced enteritis, we investigated the protective effects of atorvastatin against RT‐induced damage of the intestinal tract. In this study, C57BL/6 mice were randomly distributed into the following groups (n = 8 per group): (1) control group: mice were fed water only, (2) atorvastatin group (Ator): mice were administered atorvastatin, (3) irradiation group (IR): mice received abdominal RT, (4) Ator+IR group: mice received abdominal RT following atorvastatin administration, and (5) Ator+IR+3‐MA group: abdominal RT following atorvastatin and 3‐methyladenine (an autophagy inhibitor) administration. Based on the assessment of modified Chiu’s injury score and villus/crypt ratio, we found that atorvastatin administration significantly reduced intestinal mucosal damage induced by RT. Atorvastatin treatment reduced apoptosis (cleaved caspase‐3 and cleaved poly (ADP‐ribose) polymerase), DNA damage (γH2AX and 53BP1), oxidative stress (OS, 4‐hydroxynonenal), inflammatory molecules (phospho‐NF‐κB p65 and TGF‐β), fibrosis (collagen I and collagen III), barrier leakage (claudin‐2 and fluorescein isothiocyanate‐dextran), disintegrity (fatty acid‐binding protein 2), and dysfunction (lipopolysaccharide) caused by RT in small intestinal tissue. In addition, atorvastatin upregulated the expression of autophagy‐active molecules (LC3B), antioxidants (heme oxygenase 1 and thioredoxin 1), and tight junction proteins (occludin and zonula occludens 1). However, the biological functions of atorvastatin in decreasing RT‐induced enteritis were reversed after the administration of 3‐MA; the function of antioxidant molecules and activity of thioredoxin reductase were independent of autophagy activation. Our results indicate that atorvastatin can effectively relieve RT‐induced enteritis through autophagy activation and associated biological functions, including maintaining integrity and function and decreasing apoptosis, DNA damage, inflammation, OS, and fibrosis. It also acts via its antioxidative capabilities.

22 May 2019 in Head & Neck
Verified
Journal Article
Closed access
PDF file
JCJenny Ling-Yu Chen
Jenny Ling-Yu Chen
CSChia‐Wei Shen
Chia‐Wei Shen
CWChia‐Chun Wang
Chia‐Chun Wang
YHYu‐Sen Huang
Yu‐Sen Huang
JCJo‐Pai Chen
Jo‐Pai Chen
CWChun-Wei Wang
Chun-Wei Wang